Colloidal Systems in Drug Delivery

Research
CDD combines expertise in colloid and interface science, self-assembly, membrane biophysics and pharmaceutical technology.
We study how molecular composition, structure, morphology and size at nano- and microscales influence physicochemical properties and interactions with biological membranes and solid interfaces, modulating biological performance.
CDD covers nano-/micro-particulate drug delivery systems, including lipid nanocarriers, solid lipid particles and liquid-crystalline systems, and in situ-forming liquid crystalline depots, functional coatings, membrane-active therapeutics, antimicrobial materials, and oral and cutaneous drug delivery.
We combine biophysical and physicochemical tools with biological studies to link structural and interfacial properties with therapeutic efficacy.
Group leader
Anan Yaghmur
Professor of Pharmaceutical Physical Chemistry
Methods and Equipment
The cluster employs complementary biophysical, structural and interfacial methods to characterize colloidal systems and their interactions with biological and solid interfaces.
- SAXS/WAXS, GISAXS, SANS, and GISANS
- Neutron reflectometry
- Online SAXS/WAXS investigations, including SAXS-on-chip
- Cryo-TEM
- DLS and nanoparticle tracking analysis (NTA)
- Surface and interfacial characterization: QCM-D, ATR-FTIR, SPR, ellipsometry and AFM
- Fluorescence microscopy
- Model membrane and membrane-interaction studies
Group members
- External, Ph.d Student
- Postdoc
- PhD Student
- Professor
- Associate Professor
- Assistant Professor - Tenure Track
- Associate Professor